FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Screening tests that are non-invasive show promise in detecting colorectal cancer.

2.

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

3.

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

4.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

5.

Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot